MDD Europe 2020 Placeholder

Welcome to the 4th Microbiome Movement - Drug Development Summit Europe 2020

Despite the scientific communities progress in translating microbiome R&D into promising therapeutic candidates, academic and pharmaceutical leaders continue to identify the causal role of the human microbiome in disease to create treatments with consistent clinical outcomes and predictable molecular mechanisms.

Part of the established Microbiome Movement, the 4th Microbiome Movement – Drug Development Europe will return as the industry-defining forum to help discover, develop and deliver the next generation of microbiome-based therapeutic and diagnostic candidates to market. 

Register your interest to receive agenda and speaker updates as they are announced. 

Hear What Our Customers Say

"As a newcomer to the microbiome field, this conference provided an excellent overview.”

Richard Shanksky
Seres  Therapeutics

“It was a great conference to effectively learn the current trends in microbiome drug development around the world.”

Nanae Izumi
Daiichi Sankyo

Confirmed Partners for 2020 Include:

Atlantia
Biose Industry
Boston Analytical
CosmosID
Luina Bio
NIZO
ProDigest
Quay Pharma

Other Events In The Series